Bio-Rad Laboratoriesvs.IDEXX Laboratories
BIO vs IDXX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
IDEXX Laboratories is about 4.6× larger than Bio-Rad Laboratories by market cap; IDEXX Laboratories trades at the lower P/E (39.0 vs 43.5); year to date, Bio-Rad Laboratories leads (+26.0% vs −17.3%).
Side by side
| BIO | IDXX | |
|---|---|---|
| Market cap | $9.7B | $44.4B |
| Price | $390.34 | $550.01 |
| Today | +2.2% | −1.7% |
| Return YTD | +26.0% | −17.3% |
| Return 1Y | +25.7% | −13.3% |
| P/E | 43.5 | 39.0 |
| P/S | 3.7 | 9.8 |
| P/B | 1.3 | 27.6 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Bio-Rad LaboratoriesBIO
Clinical diagnostics laboratories buy one part of the range, blood typing among the uses; life science researchers buy the other, for work such as droplet digital PCR.
Full BIO profile →IDEXX LaboratoriesIDXX
Vets are the customers. IDEXX sells the analysers that sit in the clinic, runs the reference laboratories that handle samples sent out, and writes the software the practice runs on.
Full IDXX profile →More BIO & IDXX comparisons
Other head-to-heads in the Diagnostics segment.